National Customer Service Hotline：
400-866-5288
DE-000025
Ibrutinib
Imbruvica; PCI-32765, CRA-032765
936563-96-1
C25H24N6O2
440.51
Inert Gas, -20°C
Room Temperature
Ibrutinib is used to treat several B-cell malignancies and chronic graft-versus-host disease (cGVHD). It works by blocking a protein called Bruton's tyrosine kinase (BTK), which stops cancer cells from growing and multiplying.
Our technical experts review and provide you with tailored solutions
ZH